1. Home
  2. ATI vs HALO Comparison

ATI vs HALO Comparison

Compare ATI & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATI
  • HALO
  • Stock Information
  • Founded
  • ATI 1960
  • HALO 1998
  • Country
  • ATI United States
  • HALO United States
  • Employees
  • ATI N/A
  • HALO N/A
  • Industry
  • ATI Steel/Iron Ore
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ATI Industrials
  • HALO Health Care
  • Exchange
  • ATI Nasdaq
  • HALO Nasdaq
  • Market Cap
  • ATI 7.3B
  • HALO 7.4B
  • IPO Year
  • ATI N/A
  • HALO N/A
  • Fundamental
  • Price
  • ATI $73.94
  • HALO $50.23
  • Analyst Decision
  • ATI Strong Buy
  • HALO Buy
  • Analyst Count
  • ATI 8
  • HALO 9
  • Target Price
  • ATI $73.29
  • HALO $63.78
  • AVG Volume (30 Days)
  • ATI 2.3M
  • HALO 2.6M
  • Earning Date
  • ATI 05-01-2025
  • HALO 05-06-2025
  • Dividend Yield
  • ATI N/A
  • HALO N/A
  • EPS Growth
  • ATI 2.35
  • HALO 55.40
  • EPS
  • ATI 2.76
  • HALO 3.76
  • Revenue
  • ATI $4,463,600,000.00
  • HALO $1,084,306,000.00
  • Revenue This Year
  • ATI $7.17
  • HALO $24.79
  • Revenue Next Year
  • ATI $8.41
  • HALO $22.65
  • P/E Ratio
  • ATI $26.61
  • HALO $13.36
  • Revenue Growth
  • ATI 6.82
  • HALO 25.64
  • 52 Week Low
  • ATI $39.23
  • HALO $41.28
  • 52 Week High
  • ATI $72.28
  • HALO $70.51
  • Technical
  • Relative Strength Index (RSI)
  • ATI 82.50
  • HALO 34.42
  • Support Level
  • ATI $51.80
  • HALO $58.38
  • Resistance Level
  • ATI $75.26
  • HALO $69.94
  • Average True Range (ATR)
  • ATI 2.54
  • HALO 3.30
  • MACD
  • ATI 1.91
  • HALO -0.27
  • Stochastic Oscillator
  • ATI 94.68
  • HALO 9.30

About ATI ATI Inc.

ATI Inc supplies specialty metals to various end markets, including aerospace and defense, oil and gas, automotive, and electrical energy, among many others. The company's operating segment includes High-Performance Materials and Components and Advanced Alloys and Solutions. The majority of revenue is from the High-Performance Materials segment. The High-Performance Materials segment is focused on a wide range of high-performance specialty materials, parts, and components for several the majority of end markets, including the aerospace & defense, medical, and energy markets. Geographically, it operates in the United States, China, the United Kingdom, Germany, France, Canada, and Others, the majority is from the United States.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: